Skin Atrophy
Skin atrophy is thinning of the epidermis and dermis caused by corticosteroids. The cells shrink and lose metabolic activity, and the dermis loses connective tissue and ground substance. Clinically it shows as shiny, fragile skin that bruises easily, with visible small vessels (telangiectasia) and sometimes stretch marks (striae). It is the most-cited local side effect of Topical Corticosteroids (AFP 2009). Risk rises with potency, occlusion (including Wet Wrap Therapy and nappies), and thin-skinned sites such as the face, eyelids, axillae and groin (AFP 2009; DermNet). It is also the most common fear behind Steroid Phobia. In one Australian survey, 46% of pharmacists named atrophy as the commonest TCS side effect, and two-thirds told patients not to use TCS for more than 2 weeks at a time (Mooney 2015).
Topical Corticosteroids [causes] Skin Atrophy Skin Atrophy [causes] Steroid Phobia Wet Wrap Therapy [worsens] Skin Atrophy
Real-world incidence in children. Measured harm in children using TCS appropriately is very low. Hong, Smith & Fischer (Pediatric Dermatology 2011) followed 70 children with eczema treated with potent or moderate TCS for a mean of about 10.8 months. Validated dermoscopy at 210 treated sites and 70 untreated control sites found no atrophy (all scored 0) and no striae. Grade-1 telangiectasia occurred equally in treated and control skin (3.2% vs 3.1%). In a trial of 174 children, a 3-day burst of potent betamethasone valerate thinned skin no more than 7 days of mild steroid. The Australasian consensus (Mooney 2015) concluded that TCS “does not cause atrophy … when used appropriately as per guidelines”. Across trials, Cochrane (Lax 2022) found 26 possible thinning cases among 2,266 participants: 16 with very potent, 6 potent, 2 moderate and 2 mild steroid. No cases occurred in 1,050 people on Weekend Therapy. Axon 2021 found no excess thinning versus vehicle in 2-week trials. TCS did cause more thinning than Topical Calcineurin Inhibitors (RR 4.86; 8 cases in 2,068, 7 on potent TCS).
Skin Atrophy [relates] Weekend Therapy Topical Calcineurin Inhibitors [prevents] Skin Atrophy Hydrocortisone [relates] Skin Atrophy
Reversibility and striae. Experimental atrophy from very potent Clobetasol Propionate under occlusion reversed rapidly once stopped (Mooney 2015). AFP 2009 says resolution “often occurs after discontinuing … but it may take months”. Striae are different. They are dermal scars and permanent once formed. The evidence tying them to TCS is low level: 15 of 312 patients across case reports and small series. The Australasian panel recalled one case in over 430 person-years of paediatric practice. Striae occur naturally in 25–35% of children and teens during growth spurts, so they should not automatically be blamed on steroids. Mooney also notes that parents and non-dermatologists often mistake the skin changes of active eczema for “skin thinning”.
Skin Atrophy [relates] Atopic Dermatitis Clobetasol Propionate [causes] Skin Atrophy
Conflict: [Mooney et al., Australasian consensus, 2015] says irreversible skin thinning “does not occur” when paediatric TCS is stopped once eczema resolves. [AFP Ference & Last, 2009] lists “permanent dermal atrophy” among TCS side effects. [NICE CG57/TA82] cites “irreversible skin atrophy” as the risk that justifies switching to Pimecrolimus/Tacrolimus. The difference may reflect misuse versus appropriate use, but the sources do not reconcile it. Unresolved — add to open_questions.
Where real cases come from. The paediatric atrophy cases the Australasian panel had seen involved “off-label” use: steroid applied for months to pigment changes, at high-absorption sites (axillae, flexures, groin), often under plastic occlusion. Hidden potent steroid in Adulterated Herbal Creams (MHRA 2018) is another documented route to irreversible thinning. In those cases the parent does not know the cream contains a steroid, so they apply it without any limit on time or site.
Adulterated Herbal Creams [causes] Skin Atrophy Fingertip Unit [prevents] Skin Atrophy
Hidden steroid in "natural" creams
Unlabelled “herbal” creams can contain potent steroids such as clobetasol. Daily unsupervised use on a toddler’s face or nappy area is the scenario most linked to lasting skin damage.
Connections
- Topical Corticosteroids — local side effect of TCS, source: Cochrane 2022; AFP 2009; DermNet
- Adulterated Herbal Creams — irreversible thinning from hidden potent steroid used unsupervised, source: Ramsay ADC 2003; MHRA 2018
- Steroid Phobia — atrophy is the leading parental and pharmacist fear, source: Mooney 2015
- Topical Calcineurin Inhibitors — less thinning than TCS (RR 4.86), source: Axon 2021
- Weekend Therapy — no thinning in 7 prevention trials, source: Cochrane 2022
- Fingertip Unit — measured dosing limits overuse, source: AFP 2009
- Atopic Dermatitis — active eczema changes often misread as “thinning”, source: Mooney 2015